Jubilant Pharmaceuticals is the European subsidiary of Jubilant Organosys Ltd. (India), specialists in the R&D and production of API's and finished dosage form products.
We are a totally backward integrated service and product provider for generic pharmaceutical companies who wish to excel in first-to-market generics with a commitment to market-competitive prices during the entire term of the Supply Agreement.
Our core business and capabilities are situated in the below areas:
* Out-licensing with supply of fully in-house
developed generics, covering a wide range of
therapeutic areas
* Regulatory Services such as MRP & DCP filings,
compilation of e-CTD dossiers, etc
* Manufacturing site transfers with production at the in-
house EU-GMP approved plant in Roorkee, India
* Clinical research at the in-house facility in Delhi, India
We are a one-stop-solution through full integration of in-house API, R&D formulation, clinical center, regulatory affairs expertise, EU-GMP approved dosage form manufacturing and GDP logistics followed by EU-release.
|
|
|
11-50 employees
View all Jubilant Pharmaceuticals employees
|
|
Pharmaceuticals
|
|
None
|
|
Supply Chain, Pharmaceuticals, Europe
|
Vincent Villegas is the CEO of Jubilant Pharmaceuticals. To contact Vincent Villegas email at [email protected].
The decision makers in Jubilant Pharmaceuticals are Dr. Robert F., Samit Deb, Suresh Kumar, etc. Click to Find Jubilant Pharmaceuticals decision makers emails.
Jubilant Pharmaceuticals provides a wide range of services including contract manufacturing, drug development, and regulatory support. Their expertise spans across various dosage forms such as tablets, capsules, injectables, and more. They also offer specialized services in the areas of sterile manufacturing and controlled substances.
Jubilant Pharmaceuticals serves multiple industries including pharmaceuticals, biotechnology, and healthcare. They cater to both large pharmaceutical companies and small biotech firms, providing tailored solutions that meet the specific needs of each client. Their services are designed to support drug development from early-stage research through to commercial manufacturing.
Quality is a top priority at Jubilant Pharmaceuticals. They adhere to stringent quality control measures and comply with international regulatory standards such as FDA, EMA, and ICH guidelines. Their facilities are equipped with state-of-the-art technology, and they conduct regular audits and inspections to ensure that all processes meet the highest quality standards.
Yes, Jubilant Pharmaceuticals has a dedicated regulatory affairs team that provides comprehensive support for regulatory submissions. They assist clients in preparing and submitting documents to regulatory authorities, ensuring compliance with local and international regulations. This includes guidance on IND, NDA, ANDA, and other necessary filings.
To engage Jubilant Pharmaceuticals for contract manufacturing, clients typically start by reaching out to their business development team to discuss specific needs and requirements. Following an initial consultation, a detailed proposal is prepared, outlining the scope of work, timelines, and costs. Once both parties agree, a formal contract is established, and the project moves into the manufacturing phase.
Yes, Jubilant Pharmaceuticals offers specialized services tailored for biotech companies, including process development, scale-up, and clinical trial material manufacturing. They understand the unique challenges faced by biotech firms and provide flexible solutions that can adapt to the evolving needs of their clients throughout the drug development lifecycle.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.